New findings in Alzheimers research

November 16, 2015, Ruhr-Universitaet-Bochum

Current Alzheimer's research focuses on the amyloid precursor protein (APP), which is responsible for the formation of destructive plaques in the brain. Researchers from Bochum have now demonstrated that APP, in addition to forming those plaques, might also affect the development of Alzheimer's disease via another mechanism.

Protein in the cell membrane

Under certain circumstance, APP causes the formation of spherical structures in the nucleus, so-called spheres. They affect the activity of some genes, which may result in a modulation of neurotransmitter activity. Neurotransmitters are biochemical transmitters that transmit excitation from a nerve cell to other . APP itself is a protein that is anchored in the . In this capacity, it has several binding sites where other proteins can dock, thus triggering a number of different processes. One of the adaptor proteins is FE65. Under certain circumstances, it can enter the cell nucleus with the aid of the APP. There, FE65 together with other proteins forms the spherical structures specified above. It had previously not been understood in what way they affect the cells.

Comparison between different cell cultures

Dr Thorsten Müller from Medizinisches Proteom-Center explains how he and his PhD student Christina Looße have proceeded to gain a better understanding of the spheres' potential influence on the brain: "In our study, we have established a cell culture model inside which we can switch on specific sphere formation. The cells that have been switched on generate spheres." The researchers compared them with cells that were switched off and which did not show any sphere formation. "In the process, we discovered that sphere-forming cells exhibit higher expression of the bestrophin 1-gene," says Müller

Biochemical transmitters and Alzheimer's disease

Bestrophin 1 has recently been described in the context of impaired neurotransmitter activity in Alzheimer's disease. "Elevated levels of the neurotransmitter GABA in the cerebrospinal fluid of Alzheimer's patients have already been described, and our study may shed light on how neurotransmitter modulations correlate with the APP," as Dr Thorsten Mülller elaborates the relevance of his research work for medical science.

Starting point for future therapies

Contrary to previous assumptions, the APP could thus affect the development of Alzheimer's disease, inasmuch as it affects an inhibition of neurotransmitter activity and is not relevant as a precursor of plaques in the first place. "This hypothesis might provide interesting starting points for the development of therapies for the treatment of Alzheimer's disease," says Thorsten Müller.

Explore further: How Alzheimer's could occur: Protein spheres in the nucleus give wrong signal for cell division

More information: Christina Loosse et al. Nuclear spheres modulate the expression of BEST1 and GADD45G, Cellular Signalling (2016). DOI: 10.1016/j.cellsig.2015.10.019

Related Stories

How Alzheimer's could occur: Protein spheres in the nucleus give wrong signal for cell division

April 11, 2013
A new hypothesis has been developed by researchers in Bochum on how Alzheimer's disease could occur. They analysed the interaction of the proteins FE65 and BLM that regulate cell division. In the cell culture model, they ...

'Alzheimer protein' seems to slow down neurotransmitter production

August 21, 2012
Researchers report how abnormal protein deposits in the brains of Alzheimer's patients disrupt the signaling between nerve cells. They varied the amount of APP protein and related proteins associated with Alzheimer's disease ...

Protein repairs nerve cell damage

November 5, 2015
In laboratory experiments on the basic mechanisms that cause Alzheimer's dementia, an international research team led by Heidelberg neurobiologist Prof. Dr. Ulrike Müller and a team of French scientists have succeeded in ...

Study reveals new link between Down syndrome and Alzheimer's

November 2, 2015
Individuals with Down syndrome who survive into adulthood face the additional challenge of early-onset dementia, in which toxic amyloid plaques build up in the brain. The condition is strikingly similar to Alzheimer's disease, ...

'Alzheimer's protein' plays role in maintaining eye health and muscle strength

June 9, 2015
Amyloid precursor protein (APP), a key protein implicated in the development Alzheimer's disease, may play an important role in eye and muscle health. In a new report published in the June 2015 issue of The FASEB Journal, ...

Road block as a new strategy for the treatment of Alzheimer's

August 22, 2011
Blocking a transport pathway through the brain cells offers new prospects to prevent the development of Alzheimer's. Wim Annaert and colleagues of VIB and K.U. Leuven discovered that two main agents involved in the inception ...

Recommended for you

Meditation and music may alter blood markers of cellular aging and Alzheimer's disease

November 13, 2018
A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain biomarkers of cellular aging and Alzheimer's ...

Alzheimer's and cardiovascular disease share common genetics in some patients

November 9, 2018
Genetics may predispose some people to both Alzheimer's disease and high levels of blood lipids such as cholesterol, a common feature of cardiovascular disease, according to a new study by an international team of researchers ...

Artificial intelligence predicts Alzheimer's years before diagnosis

November 6, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer's disease, according to a study published in the journal Radiology.

Diabetes medications may reduce Alzheimer's disease severity

November 1, 2018
People with Alzheimer's disease who were treated with diabetes drugs showed considerably fewer markers of the disease—including abnormal microvasculature and disregulated gene expressions—in their brains compared to Alzheimer's ...

Massive study confirms that loneliness increases risk of dementia

October 29, 2018
A new Florida State University College of Medicine study involving data from 12,000 participants collected over 10 years confirms the heavy toll that loneliness can take on your health: It increases your risk of dementia ...

Bioactive compound from the Rhodiola plant improves memory

October 25, 2018
In an ageing society, more people are suffering from memory disorders. The progressive loss of memory severely impairs the quality of life of those affected. So far, no drugs are known to prevent age-related cognitive decline.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

baudrunner
not rated yet Nov 16, 2015
My understanding is that APP starts out as an ordinary peptide which does not pass all the way through the cell membrane because somehow in that hydrophobic layer, through some kind of enzymatic activity, it becomes misfolded and remains there to initiate the process that leads to the aggregation of plaques and tangles. If the APP precursor can be identified, then a targeting enzyme designed to break it up before it begins to permeate the cell membrane may be able to prevent this entire process from the onset. That would constitute a preventive cure.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.